Clinigen Group plc is a United Kingdom-based pharmaceutical and services company. The Company's principal activities include management, sale and distribution of pharmaceutical products, which have associated expiry dates. The Company operates through five segments: Clinigen Clinical Trial Services (CTS), which sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies; Idis Managed Access (MA), which is engaged in the consultancy, development, management and implementation of managed access programs for biotechnology and pharmaceutical companies; Idis Global Access (GA), which offers ethical access to post approval and short-supply medicines; Clinigen Specialty Pharmaceuticals (SP), which manufactures and distributes its own and in-licensed specialist, hospital-only medicines around the world, and Link Healthcare, which distributes pharmaceutical products in South Africa, and the Asia and Pacific region.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: LON:CLIN
- CUSIP: N/A
- Web: N/A
Capitalization:- Market Cap: £1.01 billion
- Outstanding Shares: 114,900,000
Average Prices:- 50 Day Moving Avg: GBX 841.89
- 200 Day Moving Avg: GBX 795.79
- 52 Week Range: GBX 492.75 - GBX 890
P/E:- Trailing P/E Ratio: 70.31683
- P/E Growth: 0.00000
Sales & Book Value:- Annual Revenue: £315.2 million
- Price / Sales: 3.20
- Book Value: GBX 2.08 per share
- Price / Book: 4.23
Profitability:Misc:- Average Volume: 362,874 shs.
Frequently Asked Questions for Clinigen Group PLC (LON:CLIN)
What is Clinigen Group PLC's stock symbol?
Clinigen Group PLC trades on the London Stock Exchange (LON) under the ticker symbol "CLIN."
How often does Clinigen Group PLC pay dividends? What is the dividend yield for Clinigen Group PLC?
Clinigen Group PLC announced a dividend on Wednesday, March 15th. Investors of record on Thursday, March 23rd will be paid a dividend of GBX 1.60 per share on Thursday, April 13th. This represents a dividend yield of 0.2%. The ex-dividend date is Thursday, March 23rd. The official announcement can be accessed at this link. View Clinigen Group PLC's Dividend History.
Where is Clinigen Group PLC's stock going? Where will Clinigen Group PLC's stock price be in 2017?
4 brokerages have issued twelve-month price targets for Clinigen Group PLC's stock. Their predictions range from GBX 895 to GBX 1,015. On average, they anticipate Clinigen Group PLC's stock price to reach GBX 957.75 in the next twelve months. View Analyst Ratings for Clinigen Group PLC.
Who are some of Clinigen Group PLC's key competitors?
Some companies that are related to Clinigen Group PLC include Amec Foster Wheeler PLC (AMFW), WS Atkins PLC (ATK), Udg Healthcare PLC (UDG), Abcam Plc (ABC), Fevertree Drinks PLC (FEVR), Sophos Group PLC (SOPH), WH Smith Plc (SMWH), Cineworld Group plc (CINE), Centamin PLC (CEY), Balfour Beatty plc (BBY), National Express Group PLC (NEX), Hutchison China MediTech Limited (HCM), Moneysupermarket.Com Group PLC (MONY), Berendsen PLC (BRSN), Burford Capital Limited (BUR), Ocado Group PLC (OCDO), Britvic Plc (BVIC) and FirstGroup plc (FGP).
Who are Clinigen Group PLC's key executives?
Clinigen Group PLC's management team includes the folowing people:
- Shaun Edward Chilton, Chief Executive Officer, Director
How do I buy Clinigen Group PLC stock?
Shares of Clinigen Group PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Clinigen Group PLC's stock price today?
One share of Clinigen Group PLC stock can currently be purchased for approximately GBX 879.
MarketBeat Community Rating for Clinigen Group PLC (LON CLIN)MarketBeat's community ratings are surveys of what our community members think about Clinigen Group PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Earnings History for Clinigen Group PLC (LON:CLIN)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Clinigen Group PLC (LON:CLIN)No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History by Quarter for Clinigen Group PLC (LON:CLIN)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 3/15/2017 | | GBX 1.60 | 0.2% | 3/23/2017 | 3/23/2017 | 4/13/2017 |
| 9/28/2016 | | GBX 2.70 | 0.38% | 11/3/2016 | 11/3/2016 | 11/25/2016 |
| 3/2/2016 | | GBX 1.30 | 0.2% | 3/17/2016 | 3/17/2016 | 4/8/2016 |
| 9/22/2015 | | GBX 2.30 | 0.32% | 10/15/2015 | 10/15/2015 | 11/6/2015 |
| 9/24/2014 | | GBX 2.10 | 0.46% | 10/16/2014 | 10/16/2014 | 11/7/2014 |
| 2/26/2014 | | GBX 1 | 0.19% | 3/5/2014 | 3/5/2014 | 3/28/2014 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for Clinigen Group PLC (LON:CLIN)Insider Trades by Quarter for Clinigen Group PLC (LON:CLIN)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 11/11/2016 | John Bacon | Insider | Sell | 200,000 | GBX 717 | £1,434,000 | |
| 10/18/2016 | Shaun Edward Chilton | Insider | Sell | 97,246 | GBX 750 | £729,345 | |
| 5/16/2016 | Abell,Martin | Insider | Buy | 11,296 | GBX 518 | £58,513.28 | |
| 10/7/2015 | Edward Chilton,Shaun | Insider | Sell | 412,778 | GBX 685 | £2,827,529.30 | |
| 6/3/2015 | John Hartup | Insider | Sell | 23,934 | GBX 644 | £154,134.96 | |
(Data available from 1/1/2013 forward)
Headline Trends for Clinigen Group PLC (LON:CLIN)
Latest Headlines for Clinigen Group PLC (LON:CLIN)
| Source: |
|
Clinigen Group PLC (CLIN) Chart for Sunday, May, 28, 2017
